|
Navigating the Expanding Neuroendocrine Tumor Treatment Arsenal: Key Advances in Targeted Therapy & Nuclear Medicine |
06/27/2025 - 8:00am to 9:00am EDT |
|
Rare Case of GEJ Adeno-Squamous Carcinoma |
07/11/2025 - 8:00am to 9:00am EDT |
|
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics |
07/18/2025 - 8:00am to 9:00am EDT |
|
Molecular Targets in Non Small Cell Lung Cancer: The Ever-Changing Landscape and New Molecular Targets |
07/25/2025 - 8:00am to 9:00am EDT |
|
Community Practice Perspectives: Exploring Treatment Intensification with CDK 4/6i in Adjuvant HR+, HER2-, High-Risk Early Breast Cancer |
09/05/2025 - 8:00am to 9:00am EDT |
|
Acute Promyelocytic Leukemia |
09/12/2025 - 8:00am to 9:00am EDT |
|
Advancing ALK Inhibition into Early-Stage NSCLC—Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection |
09/19/2025 - 8:00am to 9:00am EDT |
|
Managing Von Willebrand Disease: Special Considerations in Pregnancy |
09/26/2025 - 8:00am to 9:00am EDT |
|
Myelodysplastic Syndrome 2025 - Past, Present and Future |
10/03/2025 - 8:00am to 9:00am EDT |
|
VEXAS Syndrome |
10/10/2025 - 8:00am to 9:00am EDT |
Facebook
X
LinkedIn
Forward